5/27/2009

The FDA cleared Adcirca, United Therapeutics' treatment for pulmonary arterial hypertension. The drug was co-developed by Eli Lilly and Co. and contains the active ingredient in Lilly's erectile dysfunction medicine Cialis.

Related Summaries